The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs
- Creator: Liu, Pei Y. , Sokolowski, Nicholas , Liu, Bing , Yang, Rui H. , Guo, Xiang Y. , Tee, Andrew E. , Itoh, Ken , Wang, Jenny , Kavallaris, Maria , Haber, Michelle , Norris, Murray D. , Cheung, Belamy B. , Guo, Su T. , Byrne, Jennifer A. , Ziegler, David S. , Marshall, Glenn M. , Dinger, Marcel E. , Codd, Rachel , Zhang, Xu D. , Liu, Tao , Siddiqi, Faraz , Atmadibrata, Bernard , Telfer, Thomas J. , Sun, Yuting , Zhang, Lihong , Yu, Denise , Mccarroll, Joshua
- Resource Type: journal article
- Date: 2016
Treatment of children with poor risk solid tumors by further escalation of the VETOPEC regimen including very high-dose cyclophosphamide and peripheral stem cell support: an Australian and New Zealand Children's Hematology and Oncology Group Study
- Creator: McCowage, Geoffrey B. , Mrongovius, Robert , Alvaro, Frank , Cohn, Richard J. , Ziegler, David S. , Oswald, Cecilia , White, Les , ANZCHOG,
- Resource Type: journal article
- Date: 2011